Physician profile
Kevin Lin
NPI 1548441454
$1,488.28
in general payments reported to CMS, 2019-2025
10 companies · $49.48 in 2025
The $49.48 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.16 · 2022: $1,113 · 2023: $25.00 · 2024: $233 · 2025: $49.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $307.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflexion Medical, INC. | $1,024.62 | 2022-2023 | Reflexion Medical Radiotherapy System |
| Bioprotect Medical, INC. | $211.62 | 2024 | Bioprotect Balloon Implant System |
| Mevion_medical_systems_inc | $73.74 | 2022 | |
| Visionrt, INC. | $54.87 | 2019 | |
| Janssen Biotech, INC. | $28.69 | 2025 | Tremfya |
| Palette Life Sciences, INC. | $23.72 | 2022 | |
| Siemens Medical Solutions USA, INC. | $21.82 | 2024 | Varian Ethos Treatment Planning |
| Depuy Synthes Sales INC. | $20.79 | 2025 | Embotrap |
| Viewray Technologies INC | $16.12 | 2022 | |
| Tactile Systems Technology INC | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.